Brown Emile N, Kon Zachary N, Tran Richard, Burris Nicholas S, Gu Junyen, Laird Patrick, Brazio Philip S, Kallam Seeta, Schwartz Kimberly, Bechtel Lisa, Joshi Ashish, Zhang Shaosong, Poston Robert S
Department of Surgery, Division of Cardiac Surgery, University of Maryland School of Medicine, Baltimore, Md 21201, USA.
J Thorac Cardiovasc Surg. 2007 Nov;134(5):1259-65. doi: 10.1016/j.jtcvs.2007.07.042. Epub 2007 Sep 29.
Residual clot strands within the excised saphenous vein are an increasingly recognized sequela of endoscopic vein harvest. We hypothesized that endoscopic visualization facilitated by sealed carbon dioxide insufflation causes stagnation of blood within the saphenous vein. In the absence of prior heparin administration, this stasis provokes clot formation.
Forty consecutive patients having coronary artery bypass grafting underwent endoscopic vein harvest using sealed (Guidant VasoView, n = 30; Guidant Corp, Minneapolis, Minn) or open (Datascope ClearGlide, n = 10; Datascope Corp, Montvale, NJ) carbon dioxide insufflation followed by ex vivo assessment of intraluminal saphenous vein clot via optical coherence tomography. In the sealed carbon dioxide insufflation groups, clot formation was compared with (preheparinized, n = 20) and without (control, n = 10) heparin administration before endoscopic vein harvest, either at a fixed dose or titrated to an activated clotting time greater than 300 seconds. Risk factors for clot formation were assessed.
Residual saphenous vein clot was a universal finding in control veins (sealed carbon dioxide insufflation endoscopic vein harvest without preheparinization). At either dose used, heparin given before endoscopic vein harvest significantly decreased saphenous vein clot burden. A similar reduction in clot was observed when using open carbon dioxide insufflation endoscopic vein harvest without preheparinization. Intraoperative blood loss and blood product requirements were similar in all groups. Patient age and preoperative maximum amplitude of the thrombelastography tracing showed a linear correlation with saphenous vein clot volume.
By enabling the quantification of this issue as never before possible, optical coherence tomography screening revealed that intraluminal saphenous vein clot is frequently found after endoscopic vein harvest. Systemic heparinization before harvest or an open carbon dioxide endoscopic vein harvest system are benign changes in practice that can significantly lessen this complication.
切除的大隐静脉内残留的血栓条索是内镜下静脉采集越来越被认识到的后遗症。我们推测,密封二氧化碳充气辅助的内镜可视化会导致大隐静脉内血液淤滞。在未预先给予肝素的情况下,这种淤滞会引发血栓形成。
40例连续接受冠状动脉旁路移植术的患者接受了内镜下静脉采集,采用密封(Guidant VasoView,n = 30;Guidant公司,明尼阿波利斯,明尼苏达州)或开放(Datascope ClearGlide,n = 10;Datascope公司,蒙特瓦尔,新泽西州)二氧化碳充气,随后通过光学相干断层扫描对离体大隐静脉内血栓进行评估。在密封二氧化碳充气组中,将血栓形成情况与内镜下静脉采集前给予肝素(预肝素化,n = 20)和未给予肝素(对照组,n = 10)的情况进行比较,肝素给予方式为固定剂量或滴定至活化凝血时间大于300秒。评估血栓形成的危险因素。
对照组静脉(未预肝素化的密封二氧化碳充气内镜下静脉采集)中普遍存在大隐静脉残留血栓。在内镜下静脉采集前给予肝素,无论使用何种剂量,均显著降低了大隐静脉血栓负荷。在未预肝素化的开放二氧化碳充气内镜下静脉采集中也观察到类似的血栓减少情况。所有组的术中失血量和血液制品需求量相似。患者年龄和术前血栓弹力图描记的最大振幅与大隐静脉血栓体积呈线性相关。
光学相干断层扫描筛查以前所未有的方式实现了对该问题的量化,结果显示内镜下静脉采集后大隐静脉腔内经常发现血栓。采集前全身肝素化或开放二氧化碳内镜下静脉采集系统是在实践中可显著减少这种并发症的良性改变。